FGF23 and cardiac hypertrophy: More importantly, both miR-497 and FGF-23 have been reported to regulate cardiosphere-derived cell (CDC) differentiation, mediate myocardial ischemia-reperfusion (I/R) injury, or affect myocardial hypertrophy in various cardiovascular diseases (15–17).